You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
Medtronic
Moodys
AstraZeneca

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Darexaban


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Darexaban?

Darexaban is an investigational drug.

There have been 9 clinical trials for Darexaban. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2009.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Astellas Pharma Europe B.V., and [disabled in preview].

Recent Clinical Trials for Darexaban
TitleSponsorPhase
To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)Astellas Pharma IncPhase 1
To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)Astellas Pharma IncPhase 1
To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their EffectsAstellas Pharma IncPhase 1

See all Darexaban clinical trials

Clinical Trial Summary for Darexaban

Top disease conditions for Darexaban
Top clinical trial sponsors for Darexaban

See all Darexaban clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
AstraZeneca
Boehringer Ingelheim
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.